IL10 and tuberculosis: In other TB-treatment biomarker discovery studies [28], transient changes in some cytokine concentrations in blood, such as TNFα, MIP1α/β, IL-10 and sCD40L have been reported, such that changes observed early in TB treatment reverted to levels similar to those seen both pre-treatment and in healthy control subjects.